Tau accumulation in autosomal dominant Alzheimer's disease: a longitudinal [18F]flortaucipir study

被引:6
作者
O'Connor, Antoinette [1 ,2 ]
Cash, David M. [1 ]
Poole, Teresa [1 ,3 ]
Markiewicz, Pawel J. [4 ]
Fraser, Maggie R. [1 ]
Malone, Ian B. [1 ]
Jiao, Jieqing [4 ]
Weston, Philip S. J. [1 ]
Flores, Shaney [5 ]
Hornbeck, Russ [5 ]
McDade, Eric [6 ]
Schoell, Michael [1 ,7 ]
Gordon, Brian A. [5 ]
Bateman, Randall J. [6 ]
Benzinger, Tammie L. S. [5 ]
Fox, Nick C. [1 ,2 ]
机构
[1] UCL Queen Sq Inst Neurol, Dementia Res Ctr, London, England
[2] UK Dementia Res Inst UCL, London, England
[3] London Sch Hyg & Trop Med, Dept Med Stat, London, England
[4] UCL, Ctr Med Image Comp Med Phys & Biomed Engn, London, England
[5] Washington Univ St Louis, Dept Radiol, St Louis, MO USA
[6] Washington Univ St Louis, Dept Neurol, St Louis, MO USA
[7] Univ Gothenburg, Wallenberg Ctr Mol & Translat Med, Gothenburg, Sweden
基金
美国国家卫生研究院; 加拿大健康研究院; 英国医学研究理事会;
关键词
POSITRON-EMISSION-TOMOGRAPHY; PET PATTERNS; F-18-AV-1451; DEPOSITION; PHENOTYPE; TAUOPATHY; TRACER; BRAIN; ONSET;
D O I
10.1186/s13195-023-01234-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cortical tau accumulation is a key pathological event that partly defines Alzheimer's disease (AD) onset and is associated with cognitive decline and future disease progression. However, an improved understanding of the timing and pattern of early tau deposition in AD and how this may be tracked in vivo is needed. Data from 59 participants involved in two longitudinal cohort studies of autosomal dominant AD (ADAD) were used to investigate whether tau PET can detect and track presymptomatic change; seven participants were symptomatic, and 52 were asymptomatic but at a 50% risk of carrying a pathogenic mutation. All had baseline flortaucipir (FTP) PET, MRI and clinical assessments; 26 individuals had more than one FTP PET scan. Standardised uptake value ratios (SUVRs) in prespecified regions of interest (ROIs) were obtained using inferior cerebellar grey matter as the reference region. We compared the changes in FTP SUVRs between presymptomatic carriers, symptomatic carriers and non-carriers, adjusting for age, sex and study site. We also investigated the relationship between regional FTP SUVRs and estimated years to/from symptom onset (EYO). Compared to both non-carriers and presymptomatic carriers, FTP SUVRs were significantly higher in symptomatic carriers in all ROIs tested (p < 0.001). There were no significant regional differences between presymptomatic carriers and non-carriers in FTP SUVRs, or their rates of change (p > 0.05), although increased FTP signal uptake was seen posteriorly in some individuals around the time of expected symptom onset. When we examined the relationship of FTP SUVR with respect to EYO, the earliest significant regional difference between mutation carriers and non-carriers was detected within the precuneus prior to estimated symptom onset in some cases. This study supports preliminary studies suggesting that presymptomatic tau tracer uptake is rare in ADAD. In cases where early uptake was seen, there was often a predilection for posterior regions (the precuneus and post-cingulate) as opposed to the medial temporal lobe, highlighting the importance of examining in vivo tau uptake beyond the confines of traditional Braak staging.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] [18F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer's disease
    Whitwell, Jennifer L.
    Graff-Radford, Jonathan
    Tosakulwong, Nirubol
    Weigand, Stephen D.
    Machulda, Mary
    Senjem, Matthew L.
    Schwarz, Christopher G.
    Spychalla, Anthony J.
    Jones, David T.
    Drubach, Daniel A.
    Knopman, David S.
    Boeve, Bradley F.
    Ertekin-Taner, Nilufer
    Petersen, Ronald C.
    Lowe, Val J.
    Jack, Clifford R., Jr.
    Josephs, Keith A.
    ANNALS OF NEUROLOGY, 2018, 83 (02) : 248 - 257
  • [32] Cross-sectional associations between [18F]GTP1 tau PET and cognition in Alzheimer's disease
    Teng, Edmond
    Ward, Michael
    Manser, Paul T.
    Sanabria-Bohorquez, Sandra
    Ray, Rebecca D.
    Wildsmith, Kristin R.
    Baker, Suzanne
    Kerchner, Geoffrey A.
    Weimer, Robby M.
    NEUROBIOLOGY OF AGING, 2019, 81 : 138 - 145
  • [33] Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study
    Gordon, Brian A.
    Blazey, Tyler M.
    Su, Yi
    Hari-Raj, Amrita
    Dincer, Aylin
    Flores, Shaney
    Christensen, Jon
    McDade, Eric
    Wang, Guoqiao
    Xiong, Chengjie
    Cairns, Nigel J.
    Hassenstab, Jason
    Marcus, Daniel S.
    Fagan, Anne M.
    Jack, Clifford R., Jr.
    Hornbeck, Russ C.
    Paumier, Katrina L.
    Ances, Beau M.
    Berman, Sarah B.
    Brickman, Adam M.
    Cash, David M.
    Chhatwal, Jasmeer P.
    Correia, Stephen
    Forster, Stefan
    Fox, Nick C.
    Graff-Radford, Neill R.
    la Fougere, Christian
    Levin, Johannes
    Masters, Colin L.
    Rossor, Martin N.
    Salloway, Stephen
    Saykin, Andrew J.
    Schofield, Peter R.
    Thompson, Paul M.
    Weiner, Michael M.
    Holtzman, David M.
    Raichle, Marcus E.
    Morris, John C.
    Bateman, Randall J.
    Benzinger, Tammie L. S.
    LANCET NEUROLOGY, 2018, 17 (03) : 241 - 250
  • [34] Preclinical and clinical study on [18F]DRKXH1: a novel β-amyloid PET tracer for Alzheimer's disease
    Xu, MiaoMiao
    Guo, Jun
    Gu, JiaCheng
    Zhang, LinLin
    Liu, ZiHao
    Ding, Lin
    Fu, HongLiang
    Ma, YuFei
    Liang, Sheng
    Wang, Hui
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (02) : 652 - 663
  • [35] Autosomal dominant and sporadic late onset Alzheimer's disease share a common in vivo pathophysiology
    Morris, John C.
    Weiner, Michael
    Xiong, Chengjie
    Beckett, Laurel
    Coble, Dean
    Saito, Naomi
    Aisen, Paul S.
    Allegri, Ricardo
    Benzinger, Tammie L. S.
    Berman, Sarah B.
    Cairns, Nigel J.
    Carrillo, Maria C.
    Chui, Helena C.
    Chhatwal, Jasmeer P.
    Cruchaga, Carlos
    Fagan, Anne M.
    Farlow, Martin
    Fox, Nick C.
    Ghetti, Bernardino
    Goate, Alison M.
    Gordon, Brian A.
    Graff-Radford, Neill
    Day, Gregory S.
    Hassenstab, Jason
    Ikeuchi, Takeshi
    Jack, Clifford R., Jr.
    Jagust, William J.
    Jucker, Mathias
    Levin, Johannes
    Massoumzadeh, Parinaz
    Masters, Colin L.
    Martins, Ralph
    McDade, Eric
    Mori, Hiroshi
    Noble, James M.
    Petersen, Ronald C.
    Ringman, John M.
    Salloway, Stephen
    Saykin, Andrew J.
    Schofield, Peter R.
    Shaw, Leslie M.
    Toga, Arthur W.
    Trojanowski, John Q.
    Voeglein, Jonathan
    Weninger, Stacie
    Bateman, Randall J.
    Buckles, Virginia D.
    BRAIN, 2022, 145 (10) : 3594 - 3607
  • [36] Longitudinal flortaucipir ([18F]AV-1451) PET imaging in primary progressive apraxia of speech
    Utianski, Rene L.
    Martin, Peter R.
    Botha, Hugo
    Schwarz, Christopher G.
    Duffy, Joseph R.
    Petersen, Ronald C.
    Knopman, David S.
    Clark, Heather M.
    Butts, Alissa M.
    Machulda, Mary M.
    Jack, Clifford R., Jr.
    Lowe, Val J.
    Whitwell, Jennifer L.
    Josephs, Keith A.
    CORTEX, 2020, 124 : 33 - 43
  • [37] Parametric Estimation of Reference Signal Intensity for Semi-Quantification of Tau Deposition: A Flortaucipir and [18F]-APN-1607 Study
    Zhang, Huiwei
    Wang, Min
    Lu, Jiaying
    Bao, Weiqi
    Li, Ling
    Jiang, Jiehui
    Zuo, Chuantao
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [39] Amyloid beta plaque accumulation with longitudinal [18F]AZD4694 PET
    Therriault, Joseph
    Lussier, Firoza Z.
    Tissot, Cecile
    Chamoun, Mira
    Stevenson, Jenna
    Rahmouni, Nesrine
    Pallen, Vanessa
    Bezgin, Gleb
    Servaes, Stijn
    Kunach, Peter
    Wang, Yi-Ting
    Fernandez-Arias, Jaime
    Vermeiren, Marie
    Pascoal, Tharick A.
    Massarweh, Gassan
    Vitali, Paolo
    Soucy, Jean-Paul
    Saha-Chaudhuri, Paramita
    Gauthie, Serge
    Rosa-Neto, Pedro
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2023, 15 (03)
  • [40] Recent Advances in Imaging of Preclinical, Sporadic, and Autosomal Dominant Alzheimer's Disease
    Buckley, Rachel F.
    NEUROTHERAPEUTICS, 2021, 18 (02) : 709 - 727